The Valley Desk

NCT05144256 · Interventional trial

A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period

Overall registry status Active not recruiting

Phase 3

Conditions Pediatric Hemolytic Anemia, Pediatric Pyruvate Kinase Deficiency

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov